OBJECTIVE: To determine the effectiveness of Gram staining of tracheal aspirates for predicting causative microorganisms and guiding appropriate initial antibiotic therapy to treat ventilator-associated pneumonia (VAP) in extremely preterm neonates. STUDY DESIGN: A prospective study was conducted on all episodes of presumed VAP in neonates with a gestational age below 28 weeks at birth. RESULT: Gram-positive cocci and Gram-negative bacilli were the causative microorganisms in 11 and 38 confirmed episodes of VAP, respectively. The sensitivity and specificity of Gram staining were 82 and 100% for Gram-positive VAP and 100 and 82% for Gram-negative VAP, respectively. The initial antibiotic therapies based on Gram-stain findings were appropriate for 96% (47/49) of patients with VAP. CONCLUSION: Gram staining of tracheal aspirates is useful in predicting classes of causative microorganisms and for guiding appropriate initial antibiotic therapy for VAP in extremely preterm neonates.
OBJECTIVE: To determine the effectiveness of Gram staining of tracheal aspirates for predicting causative microorganisms and guiding appropriate initial antibiotic therapy to treat ventilator-associated pneumonia (VAP) in extremely preterm neonates. STUDY DESIGN: A prospective study was conducted on all episodes of presumed VAP in neonates with a gestational age below 28 weeks at birth. RESULT: Gram-positive cocci and Gram-negative bacilli were the causative microorganisms in 11 and 38 confirmed episodes of VAP, respectively. The sensitivity and specificity of Gram staining were 82 and 100% for Gram-positive VAP and 100 and 82% for Gram-negative VAP, respectively. The initial antibiotic therapies based on Gram-stain findings were appropriate for 96% (47/49) of patients with VAP. CONCLUSION: Gram staining of tracheal aspirates is useful in predicting classes of causative microorganisms and for guiding appropriate initial antibiotic therapy for VAP in extremely preterm neonates.
Authors: Anouk Goerens; Dirk Lehnick; Michael Büttcher; Karin Daetwyler; Matteo Fontana; Petra Genet; Marco Lurà; Davide Morgillo; Sina Pilgrim; Katharina Schwendener-Scholl; Nicolas Regamey; Thomas J Neuhaus; Martin Stocker Journal: Front Pediatr Date: 2018-09-24 Impact factor: 3.418